Allena Pharmaceuticals Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Allena Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Allena Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Allena Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 35 M | |
| Total Cashflows From Investing Activities | -667 K |
Allena |
Allena Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Allena Pharmaceuticals on December 24, 2024 and sell it today you would earn a total of 100.00 from holding Allena Pharmaceuticals or generate -100.0% return on investment over 90 days. Allena Pharmaceuticals is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Allena, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Allena Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Allena Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Allena Pharmaceuticals, and traders can use it to determine the average amount a Allena Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ALNAQ |
Based on monthly moving average Allena Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allena Pharmaceuticals by adding Allena Pharmaceuticals to a well-diversified portfolio.
Allena Pharmaceuticals Fundamentals Growth
Allena Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Allena Pharmaceuticals, and Allena Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Allena Pink Sheet performance.
| Return On Equity | -5.41 | |||
| Return On Asset | -1.07 | |||
| Current Valuation | (181.84 K) | |||
| Shares Outstanding | 122.08 M | |||
| Price To Book | 0.30 X | |||
| EBITDA | (47.29 M) | |||
| Cash And Equivalents | 6.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 5.28 M | |||
| Debt To Equity | 1.41 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (45.68 M) | |||
| Total Asset | 34.76 M | |||
Things to note about Allena Pharmaceuticals performance evaluation
Checking the ongoing alerts about Allena Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Allena Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Allena Pharmaceuticals is not yet fully synchronised with the market data | |
| Allena Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Allena Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (48.66 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Allena Pharmaceuticals has accumulated about 6.59 M in cash with (45.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. |
- Analyzing Allena Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allena Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Allena Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Allena Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allena Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Allena Pharmaceuticals' pink sheet. These opinions can provide insight into Allena Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |